Author:
Bongiovanni Alberto,Liverani Chiara,Foca Flavia,Bergamo Francesca,Leo Silvana,Pusceddu Sara,Gelsomino Fabio,Brizzi Maria Pia,Di Meglio Giovanni,Spada Francesca,Tamberi Stefano,Lolli Ivan,Cives Mauro,Marconcini Riccardo,Pucci Francesca,Berardi Rossana,Antonuzzo Lorenzo,Badalamenti Giuseppe,Santini Daniele,Recine Federica,Vanni Silvia,Tebaldi Michela,Severi Stefano,Rudnas Britt,Nanni Oriana,Ranallo Nicoletta,Crudi Laura,Calabrò Luana,Ibrahim Toni
Reference32 articles.
1. Neuroendocrine tumors, version 1.2015;Kulke;J Natl Compr Canc Netw,2015
2. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors;Modlin;J Natl Cancer Inst,2008
3. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008
4. WHO Classification of Tumours Editorial Board: 2022 WHO classification of endocrine and neuroendocrine tumours. Lyon, France, IARC, 2022.
5. Extrapulmonary poorly differentiated NECs, including molecular and immune aspects;McNamara;Endocr Relat Cancer,2020